0
0
Read Time:12 Second
Biotechnology major Biocon on Saturday said it will fully integrate Biocon Biologics with itself, in a deal valuing the biologics unit at $5.5 billion. As part of the transaction, Biocon will acquire the remaining stake in Biocon Biologics Ltd. from…
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %